Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
A Strategy for Simultaneous Engineering of Interspecies Cross-Reactivity, Thermostability, and Expression of a Bispecific 5T4 x CD3 DART® Molecule for Treatment of Solid Tumors.
Journal: Antibodies (Basel, Switzerland)
Published: October 17, 2024
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule.
Journal: Cell reports. Medicine
Published: September 06, 2020
Potential use of Rubidium-82 PET to differentiate neoplasms from inflammatory lesion: Case report.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: September 01, 2020
Multispecific, Multivalent Antibody-Based Molecules Engineered on the DART® and TRIDENTTM Platforms.
Multispecific, Multivalent Antibody-Based Molecules Engineered on the DART® and TRIDENTTM Platforms.
Journal: Current protocols in immunology
Published: April 16, 2020
Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer.
Journal: Molecular cancer therapeutics
Published: November 08, 2017
Showing 1-6 of 6
Last Updated: 09/26/2026